Previous randomized trials have shown that metformin lowers risk for developing long covid when started soon after infection.
See these past posts:
↪ COVID-OUT: early metformin cut long Covid risk by 42% in a large randomized trial
↪ Metformin cuts long COVID risk in two large randomized trials, COVID-OUT and ACTIV-6
↪ Starting metformin at acute COVID infection lowers long COVID risk in two large RCTs
↪ Metformin cut SARS-CoV-2 viral load 3.6-fold in the COVID-OUT randomized trial
But this latest trial shows no benefit of metformin in patients who already have long covid.
#covidHD #longcovidHD #metforminHD #metformincovidHD #longcovidHD




